Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins: the new aspirin?

N R Veillard1, F Mach

  • 1Cardiology Division, Department of Medicine, University Hospital Geneva, Foundation for Medical Research, 64 Avenue Roseraie, 1211 Geneva 4, Switzerland.

Cellular and Molecular Life Sciences : CMLS
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship of the Healthy Diet Characteristics Recommended by the 2021 ESC Guidelines with Vascular Events in Patients with Established CVD.

European journal of preventive cardiology·2025
Same author

Best Poster Award - Third Prize: The Perilousness of Antidepressant Drugs in a Real-world Cohort of Patients with Acute Coronary Syndrome.

European cardiology·2020
Same author

[My patient is too old for a lipid-lowering therapy: myths and reality].

Revue medicale suisse·2016
Same author

[The war is over -- let us learn to work together].

Revue medicale suisse·2015
Same author

Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.

Thrombosis and haemostasis·2015
Same author

[Keep a critical mind!].

Revue medicale suisse·2014

Statins, or 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are effective cholesterol-lowering drugs that significantly reduce cardiovascular events. Beyond lipid reduction, statins offer pleiotropic effects influencing vascular health and plaque stability.

Area of Science:

  • Pharmacology and Cardiovascular Medicine

Background:

  • 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, known as statins, are primary drugs for lowering serum cholesterol.
  • Statin therapy is proven to significantly reduce cardiovascular events like heart attack and stroke.

Purpose of the Study:

  • To review the detailed targets and mechanisms of action of statins.
  • To explore the pleiotropic, non-lipid-related effects of statins.

Main Methods:

  • This is a review article, synthesizing existing research on statin mechanisms.
  • Focuses on both cholesterol-lowering and non-lipid-related actions.

Main Results:

  • Statins effectively reduce cardiovascular events by altering atherosclerosis.
  • Pleiotropic effects include modulation of endothelial function, inflammation, smooth muscle cell activity, plaque stability, and thrombus formation.

Related Experiment Videos

  • Benefits of statins generally outweigh undesirable effects.

    • Conclusions:

    • Statins are crucial for managing hypercholesterolemia and reducing cardiovascular risk.
    • Their multifaceted actions extend beyond cholesterol reduction, impacting various aspects of vascular biology.